What causes elevated levels of tissue factor (TF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Abnormal levels of tissue factor can occur due to various pathological conditions, with cancer being a significant contributor, as tumor cells often produce excessive tissue factor, leading to a hypercoagulable state and increased risk of thrombosis, as supported by the most recent study 1.

Pathological Conditions Contributing to Abnormal Tissue Factor Levels

Abnormal levels of tissue factor can be caused by several factors, including:

  • Inflammatory conditions like sepsis, atherosclerosis, or cancer, where inflammation activates cells to express more tissue factor
  • Autoimmune disorders like antiphospholipid syndrome, which can increase tissue factor expression
  • Vascular injuries, such as those occurring during surgery or trauma, which expose tissue factor to blood, triggering coagulation
  • Certain medications, including hormonal therapies like estrogen-containing contraceptives, which can upregulate tissue factor

Cancer and Tissue Factor

In cancer specifically, tumor cells often produce excessive tissue factor, contributing to the hypercoagulable state and increased risk of thrombosis seen in cancer patients, as shown in studies 1. The release of tissue factor by tumor cells can directly activate the coagulation cascade, leading to thrombosis. Additionally, tissue factor can stimulate angiogenesis, which is critical to the growth of solid tumors.

Clinical Significance

These abnormalities in tissue factor levels are clinically significant because they can lead to either excessive clotting (thrombosis) or inadequate clotting (bleeding), depending on whether levels are increased or decreased. The most recent study 1 highlights the importance of considering tissue factor levels in cancer patients, as high levels of tissue factor expression have been shown to predict poor prognosis in patients with ovarian and pancreatic cancers.

From the Research

Abnormal Levels of Tissue Factor

Abnormal levels of tissue factor can be caused by various factors, including:

  • Pathological conditions such as septic shock, atherosclerosis, and cancer, which can lead to aberrant expression of tissue factor by endothelial cells, monocytes, or macrophages 2
  • Trauma, which can cause the release of constitutively expressed tissue factor into the circulation and induce tissue factor expression on monocytes and other cells 3
  • Cellular necrosis, which can result in the release of endogenous cell surface-bound tissue factor 4
  • Inflammation, which can lead to increased levels of tissue factor 4

Conditions Associated with Abnormal Tissue Factor Levels

Abnormal levels of tissue factor have been associated with various conditions, including:

  • Cancer, where tissue factor is produced by tumor-associated macrophages and plays a role in tumor growth and dissemination 2
  • Sepsis, where inducible tissue factor expression on monocytes leads to disseminated intravascular coagulation 5
  • Atherosclerosis, where tissue factor is expressed on macrophage foam cells and microvesicles, driving thrombus formation after plaque rupture 5
  • Trauma, where tissue factor plays a role in organ dysfunction and multiple organ dysfunction syndrome 3

Measurement of Tissue Factor Levels

Tissue factor levels can be measured in various biological fluids, including:

  • Plasma, where normal levels of tissue factor antigen are around 165 +/- 139 pg/ml 4
  • Serum, where normal levels of tissue factor antigen are around 165 +/- 110 pg/ml 4
  • Other fluids, such as cerebrospinal fluid, peritoneal fluid, pleural effusion, and urine, where tissue factor levels can vary depending on the condition 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tissue factor in trauma and organ dysfunction.

Seminars in thrombosis and hemostasis, 2006

Research

Tissue factor antigen levels in various biological fluids.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1995

Research

Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.

Arteriosclerosis, thrombosis, and vascular biology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.